Literature DB >> 12190095

Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.

H Skovbjerg1, O Norén, D Anthonsen, J Moller, H Sjöström.   

Abstract

BACKGROUND: Deamidation of distinct glutamines in HLA-DQ2 restricted gliadin epitopes, considered critical in the pathogenesis of coeliac disease (CD), can be mediated by tissue transglutaminase (tTG). To elucidate the possible role of other transglutaminases in CD we investigated whether different mammalian, microbial and vegetable transglutaminases can use gliadin as substrate.
METHODS: Studies in which small amounts of transglutaminase have been measured have led to our modifying a microtitre plate assay. We used proteolytically digested gliadin as solid phase substrate and Europium-labelled streptavidine to quantify the biotinylated product covalently linked by the enzyme to the plate.
RESULTS: The modified assay is ultrasensitive and quantitative, measuring guinea pig liver transglutaminase concentrations between 0.5 and 50 ng/well. The specific activities of the enzymes (counts/min/mg) against gliadin and N,N-dimethylcasein, respectively, are: tTG 9800/4900, Factor XIII 97330/55620, epidermal transglutaminase 47650/50770, streptoverticillium transglutaminase 4290/2200, phytophora cactorum transglutaminase 6910/4110. For the first time, we have detected transglutaminase activity in bean sprouts, spinach leaves and green peas, which are commonly used Vegetables.
CONCLUSION: Gliadin is a good substrate for endogenous, microbial and plant transglutaminases. An interesting altemative is that gliadins are deamidated by microbial or food transglutaminases in the intestinal lumen. The assay described provides an ultrasensitive method for measuring small amounts of transglutaminase and is considered a helpful tool in further studies of the possible role of transglutaminases in the pathogenesis of CD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190095

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  12 in total

Review 1.  Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope.

Authors:  Torsten Matthias; Sascha Pfeiffer; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 2.  Novel trends in celiac disease.

Authors:  Torsten Matthias; Sandra Neidhöfer; Sascha Pfeiffer; Kai Prager; Sandra Reuter; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 3.  Progress in lanthanides as luminescent probes.

Authors:  I Hemmilä; V Laitala
Journal:  J Fluoresc       Date:  2005-07       Impact factor: 2.217

4.  Deamidation of gliadin peptides in lamina propria: implications for celiac disease.

Authors:  H Skovbjerg; D Anthonsen; E Knudsen; H Sjöström
Journal:  Dig Dis Sci       Date:  2008-08-05       Impact factor: 3.199

5.  Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases.

Authors:  F Ferrara; S Quaglia; I Caputo; C Esposito; M Lepretti; S Pastore; R Giorgi; S Martelossi; G Dal Molin; N Di Toro; A Ventura; T Not
Journal:  Clin Exp Immunol       Date:  2009-11-12       Impact factor: 4.330

Review 6.  Dermatitis herpetiformis: from the genetics to the development of skin lesions.

Authors:  Diletta Bonciani; Alice Verdelli; Veronica Bonciolini; Antonietta D'Errico; Emiliano Antiga; Paolo Fabbri; Marzia Caproni
Journal:  Clin Dev Immunol       Date:  2012-06-07

Review 7.  Parallels between pathogens and gluten peptides in celiac sprue.

Authors:  Michael T Bethune; Chaitan Khosla
Journal:  PLoS Pathog       Date:  2008-02       Impact factor: 6.823

8.  Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  Nutr Rev       Date:  2015-06-16       Impact factor: 7.110

9.  Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with α2-gliadin or gluten.

Authors:  Niklas Engström; Ann-Sofie Sandberg; Nathalie Scheers
Journal:  Nutrients       Date:  2015-03-25       Impact factor: 5.717

10.  Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl2 as detoxifiers.

Authors:  N Engstrom; P Saenz-Méndez; J Scheers; N Scheers
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.